↑ Rising
Business
Eli Lilly takes aim at illicit market for its experimental weight-loss drug
Eli Lilly targets the illicit market for its unapproved obesity drug retatrutide through new legal actions.
2 trends tracked about this subject — the full history, oldest to newest below.
Eli Lilly targets the illicit market for its unapproved obesity drug retatrutide through new legal actions.
Peptides surge into spotlight, from hair‑loss hopes to black‑market debates and a new U.S. fentanyl link.